Skip to main content

Medtronic Expands U.S. CGM Portfolio with FDA Approval of Simplera Sync™ Sensor for MiniMed™ 780G System

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 5, 2025 – Medtronic plc (NYSE: MDT), a global leader in healthcare technology, has received U.S. Food and Drug Administration (FDA) approval for its Simplera Sync™ sensor, marking a significant expansion of its continuous glucose monitoring (CGM) portfolio in the United States. The approval enables integration of the Simplera Sync™ sensor with the company’s flagship MiniMed™ 780G system, offering greater flexibility and convenience to people managing diabetes through advanced insulin delivery technology.

Medtronic Moves Closer to Interoperable Diabetes Management with FDA Submissions for Abbott CGM Integration

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 5, 2025 – Medtronic plc (NYSE: MDT), a global leader in healthcare technology, has officially submitted 510(k) applications to the U.S. Food and Drug Administration (FDA) for its MiniMed™ 780G pump and SmartGuard™ algorithm, paving the way for seamless integration with Abbott’s advanced continuous glucose monitoring (CGM) platform. This critical regulatory milestone strengthens Medtronic’s strategic partnership with Abbott and positions the company to deliver more interoperable, intelligent diabetes care solutions to the U.S. market.

Medtronic Gains FDA Approval for World's Smallest-Diameter Defibrillation Lead, Unlocking New Frontiers in Electrophysiology

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 5, 2025 – Medtronic plc (NYSE: MDT), a global leader in healthcare technology, has received U.S. Food and Drug Administration (FDA) approval for the OmniaSecure™ defibrillation lead—the smallest-diameter, catheter-delivered defibrillation lead for right ventricular implantation. This approval marks a major advancement in cardiac rhythm management, offering physicians a less invasive, highly durable solution to treat life-threatening arrhythmias in both adults and adolescents with smaller anatomies.

Medtronic’s Expand URO Study Demonstrates Strong Safety and Efficacy Results for Hugo™ Robotic-Assisted Surgery System

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 5, 2025 – Medtronic has announced a major milestone for its Hugo™ robotic-assisted surgery (RAS) system, as the Expand URO U.S. clinical trial met both primary safety and effectiveness endpoints. The results position the company for strategic market entry into the U.S. robotic-assisted surgery sector, the largest of its kind globally, and were presented as a late-breaking session at the American Urologic Association (AUA) annual meeting in Las Vegas.

Landmark Trial Sets New Benchmark in Robotic Urologic Surgery

Medtronic Advances AFib Treatment with Promising Data on Next-Generation Pulsed Field Ablation Technologies

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 5, 2025 – Medtronic plc (NYSE: MDT) has announced encouraging one-year clinical outcomes for its investigational Affera™ pulsed field ablation (PFA) technologies, reinforcing its strategic leadership in arrhythmia management.

Post-Endodontic Restoration Gains Strategic Focus in Dentistry for Enhanced Longevity and Structural Integrity

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 5, 2025 – In the evolving landscape of restorative dentistry, post-endodontic restoration has emerged as a cornerstone of long-term tooth preservation strategies, offering clinicians and patients alike a pathway to restore function, aesthetics, and durability following root canal therapy. New insights from recent clinical literature highlight the increasing relevance of this specialized restorative approach for practitioners focused on optimizing patient outcomes and return on investment in dental care.

Orthognathic Surgery Re-Emerges as Strategic Solution for Complex Skeletal Malocclusions

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 5, 2025 – In a dental landscape increasingly dominated by minimally invasive approaches, orthognathic surgery—supported by pre- and post-surgical orthodontics—is regaining prominence as a critical solution for addressing complex skeletal deformities that fall beyond the scope of traditional orthodontics.

Digital Dentistry Reshaping Aesthetic Treatment: Benefits, Innovations, and Market Impacts

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 5, 2025 – The integration of digital technology in dentistry is revolutionizing how dental professionals approach aesthetic treatments, offering enhanced predictability, improved patient engagement, and cross-disciplinary collaboration—while also presenting operational and financial challenges for broader adoption.

Chemical and Biological Safety in Dental Disinfection: A Critical Operational Imperative for Modern Practices

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 5, 2025 – As dental clinics across the globe continue to strengthen their infection control protocols, the proper use of disinfectants remains a cornerstone of safety. While these products play a pivotal role in preventing cross-infections, recent analyses underscore the need for heightened awareness of the associated chemical and biological risks—making the responsible use of dental disinfectants a strategic imperative for operational safety and compliance.

Balancing Infection Control with Occupational Safety

Ecosite Elements Showcased in Inside Dentistry for Breakthrough Esthetic Restoration

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 5, 2025 – Ecosite Elements, a leading composite restorative solution, has been prominently featured in the May 2025 issue of Inside Dentistry, spotlighting its clinical effectiveness through a comprehensive case report authored by Dr. Jeff Lineberry. The report highlights a 32-year-old patient presenting with multiple anterior tooth fractures, successfully treated using Ecosite Elements for a highly esthetic and functional outcome.